Science Explorer Back to mapMap
Discussion
Researcher · NSABP Foundation · United States

Soonmyung Paik

Soonmyung Paik publishes mostly in Oncology, Cancer Research and Molecular Biology, on topics such as Breast Cancer Treatment Studies, HER2/EGFR in Cancer Research and Cancer Genomics and Diagnostics.

ORCID 0000-0001-9688-6480 OpenAlex
World rank
#23,441
of 7,710,434 ranked researchers
Rank in United States
#8,677
of 1,627,098
Works
341
Citations
65k
Citations per work
190.7
h-index
75
i10-index 166Top 1.1% in Oncology
Soonmyung Paik

What does Soonmyung Paik research?

Soonmyung Paik's work is mostly in Biochemistry, Genetics and Molecular Biology (42%), Medicine (42%).

Life Sciences: 142 works · 41.7% of their workBiochemistry, Genetics and Molecular Biology: 142 works · 41.7% of their workCancer Research: 75 works · 22.1% of their workMolecular Biology: 38 works · 11.2% of their workGenetics: 29 works · 8.4% of their workHealth Sciences: 142 works · 41.7% of their workMedicine: 142 works · 41.7% of their workOncology: 86 works · 25.3% of their workPulmonary and Respiratory Medicine: 31 works · 9.0% of their workPathology and Forensic Medicine: 25 works · 7.4% of their workEverything else: 57 works · 16.6% of their workTHEIR WORKSoonmyung Paik341works
Life Sciences42%Health Sciences42%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology14241.7%
    1. Medicine14241.7%
  3. Everything else5716.6%
  1. 1Oncology25% of their works
  2. 2Cancer Research22% of their works
  3. 3Molecular Biology11% of their works
  4. 4Pulmonary and Respiratory Medicine9% of their works
  5. 5Genetics8% of their works
  6. 6Pathology and Forensic Medicine7% of their works

Research topics

Which keywords describe Soonmyung Paik's research?

The keywords of their largest research topics: Molecular Subtypes, Breast Cancer, Breast Tumours, Gene Expression, Chemotherapy, Metastatic Breast Cancer, HER2 and Trastuzumab.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 20 words, with their numbers
  1. Molecular Subtypes1542 topics
  2. Breast Cancer1463 topics
  3. Breast Tumours1261 topic
  4. Gene Expression1261 topic
  5. Chemotherapy962 topics
  6. Metastatic Breast Cancer742 topics
  7. HER2681 topic
  8. Trastuzumab681 topic
  9. Cancer Genomics431 topic
  10. Mutational Signatures431 topic
  11. CDK4/6 Inhibitors401 topic
  12. Palbociclib401 topic
  13. Estrogen381 topic
  14. Receptor381 topic
  15. Chemotherapy-Induced Peripheral Neuropathy341 topic
  16. Taxanes341 topic
  17. Cetuximab281 topic
  18. KRAS Mutations281 topic
  19. Microsatellite Instability271 topic
  20. Molecular Characterization271 topic

Where does Soonmyung Paik work?

Soonmyung Paik's main affiliation in the publication record is NSABP Foundation, United States.

How many publications and citations does Soonmyung Paik have?

OpenAlex counts 341 works and 65,024 citations for Soonmyung Paik, an h-index of 75, ranking #23,441 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Soonmyung Paik. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.